X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
0
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
0
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215715
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-17-2023-88450.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-5-2023-55870.pdf
https://www.prnewswire.com/news-releases/biohaven-and-pfizer-receive-positive-chmp-opinion-for-migraine-treatment-301490453.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209358
https://www.thepharmaletter.com/article/abbvie-s-qulipta-set-to-become-blockbuster-in-the-migraine-market?__cf_chl_jschl_tk__=pmd_IewK0pA8QQtP2vk1_rS3G8.92Ymw7t1Mw5U9pVDsg0o-1634112400-0-gqNtZGzNApCjcnBszQsR
https://www.fool.com/investing/2018/03/14/is-gilead-sciences-trying-to-put-itself-out-of-bus.aspx
http://www.fiercebiotech.com/biotech/amgen-losing-confidence-novartis-partnered-migraine-program
http://www.reuters.com/article/us-alder-study-idUSKCN0WU0SZ
http://www.digitaljournal.com/life/health/new-alzheimer-s-and-migraine-treatments-being-developed/article/443011?
Market Place
Share 
